ReferencesYang, C. S., & Wang, H. (2016). “Cancer Preventive Activities of Tea Catechins.” Molecules, 21(12), 1679. https://doi.org/10.3390/molecules21121679Heaney, R. P., et al. (2008). “Milk and IGF-1: A Link to Cancer?” Journal of the American College of Nutrition, 27(6), 641-652.McCarty, M. F., & DiNicolantonio, J. J. (2015). “Minimizing Acrylamide in Coffee.” Open Heart, 2(1), e000103. https://doi.org/10.1136/openhrt-2014-000103Fuhrman, J. (2011). Eat to Live: The Amazing Nutrient-Rich Program for Fast and Sustained Weight Loss. Little, Brown and Company.

<description>&lt;p&gt;&lt;strong&gt;References&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;Yang, C. S., &amp; Wang, H. (2016). “Cancer Preventive Activities of Tea Catechins.” &lt;i&gt;Molecules&lt;/i&gt;, 21(12), 1679. https://doi.org/10.3390/molecules21121679&lt;/p&gt;&lt;p&gt;Heaney, R. P., et al. (2008). “Milk and IGF-1: A Link to Cancer?” &lt;i&gt;Journal of the American College of Nutrition&lt;/i&gt;, 27(6), 641-652.&lt;/p&gt;&lt;p&gt;McCarty, M. F., &amp; DiNicolantonio, J. J. (2015). “Minimizing Acrylamide in Coffee.” &lt;i&gt;Open Heart&lt;/i&gt;, 2(1), e000103. https://doi.org/10.1136/openhrt-2014-000103&lt;/p&gt;&lt;p&gt;Fuhrman, J. (2011). &lt;i&gt;Eat to Live: The Amazing Nutrient-Rich Program for Fast and Sustained Weight Loss.&lt;/i&gt; Little, Brown and Company.&lt;/p&gt;&lt;p&gt; &lt;/p&gt;
</description>

Discover which drinks are truly healthy and which ones to avoid, as Dr. Joel Fuhrman breaks down hydration myths, the dangers of liquid calories, and smarter alternatives like green tea, smoothies, and clean water.

The Science-Backed Guide to Beverages

References<ol><li>Chitnis MM, Yuen JS, Protheroe AS, et al. The type 1 insulin-like growth factor receptor pathway.Clin Cancer Res 2008,14:6364-6370.</li><li>Werner H, Bruchim I. The insulin-like growth factor-I receptor as an oncogene.Arch Physiol Biochem 2009, 115:58-71.</li><li>Davies M, Gupta S, Goldspink G, Winslet M. The insulin-like growth factor system and colorectal cancer: clinical and experimental evidence.Int J Colorectal Dis 2006, 21:201-208.</li><li>Sandhu MS, Dunger DB, Giovannucci EL. Insulin, insulin-like growth factor-I (IGF-I), IGF binding proteins, their biologic interactions, and colorectal cancer.J Natl Cancer Inst 2002, 94:972-980.</li><li>Kaaks R. Nutrition, insulin, IGF-1 metabolism and cancer risk: a summary of epidemiological evidence.Novartis Found Symp 2004, 262:247-260; discussion 260-268.</li><li>Lamberts SW, van den Beld AW, van der Lely AJ. The endocrinology of aging.Science 1997, 278:419-424.</li><li>Doi T, Shimada H, Makizako H, et al. Association of insulin-like growth factor-1 with mild cognitive impairment and slow gait speed.Neurobiol Aging 2015, 36:942-947.</li><li>Calvo D, Gunstad J, Miller LA, et al. Higher serum insulin-like growth factor-1 is associated with better cognitive performance in persons with mild cognitive impairment.Psychogeriatrics 2013, 13:170-174.</li><li>Thissen JP, Ketelslegers JM, Underwood LE. Nutritional regulation of the insulin-like growth factors.Endocr Rev 1994,15:80-101.</li><li>Clemmons DR, Seek MM, Underwood LE. Supplemental essential amino acids augment the somatomedin-C/insulin-like growth factor I response to refeeding after fasting.Metabolism 1985, 34:391-395.</li><li>Runchey SS, Pollak MN, Valsta LM, et al. Glycemic load effect on fasting and post-prandial serum glucose, insulin, IGF-1 and IGFBP-3 in a randomized, controlled feeding study.Eur J Clin Nutr 2012, 66:1146-1152.</li><li>Brand-Miller JC, Liu V, Petocz P, Baxter RC. The glycemic index of foods influences postprandial insulin-like growth factor-binding protein responses in lean young subjects.Am J Clin Nutr 2005, 82:350-354.</li><li>Biddinger SB, Ludwig DS. The insulin-like growth factor axis: a potential link between glycemic index and cancer.Am J Clin Nutr 2005, 82:277-278.</li><li>Burgers AM, Biermasz NR, Schoones JW, et al. Meta-analysis and dose-response metaregression: circulating insulin-like growth factor I (IGF-I) and mortality.J Clin Endocrinol Metab 2011, 96:2912-2920.</li><li>Ranke MB, Osterziel KJ, Schweizer R, et al. Reference levels of insulin-like growth factor I in the serum of healthy adults: comparison of four immunoassays.Clin Chem Lab Med 2003, 41:1329-1334.</li><li>Bidlingmaier M, Friedrich N, Emeny RT, et al. Reference intervals for insulin-like growth factor-1 (igf-i) from birth to senescence: results from a multicenter study using a new automated chemiluminescence IGF-I immunoassay conforming to recent international recommendations.J Clin Endocrinol Metab 2014, 99:1712-1721.</li><li>Brabant G, von zur Muhlen A, Wuster C, et al. Serum insulin-like growth factor I reference values for an automated chemiluminescence immunoassay system: results from a multicenter study.Horm Res 2003, 60:53-60.</li><li>Crowe FL, Key TJ, Allen NE, et al. The association between diet and serum concentrations of IGF-I, IGFBP-1, IGFBP-2, and IGFBP-3 in the European Prospective Investigation into Cancer and Nutrition.Cancer Epidemiol Biomarkers Prev 2009,18:1333-1340.</li><li>Fontana L, Klein S, Holloszy JO. Long-term low-protein, low-calorie diet and endurance exercise modulate metabolic factors associated with cancer risk.Am J Clin Nutr 2006, 84:1456-1462.</li><li>Fontana L, Weiss EP, Villareal DT, et al. Long-term effects of calorie or protein restriction on serum IGF-1 and IGFBP-3 concentration in humans.Aging Cell 2008, 7:681-687.</li><li>Friedrich N, Haring R, Nauck M, et al. Mortality and serum insulin-like growth factor (IGF)-I and IGF binding protein 3 concentrations.J Clin Endocrinol Metab 2009, 94:1732-1739.</li><li>Carlzon D, Svensson J, Petzold M, et al. Both low and high serum IGF-1 levels associate with increased risk of cardiovascular events in elderly men.J Clin Endocrinol Metab 2014, 99:E2308-2316.</li><li>Svensson J, Carlzon D, Petzold M, et al. Both low and high serum IGF-I levels associate with cancer mortality in older men.J Clin Endocrinol Metab 2012, 97:4623-4630. .</li><li>van Bunderen CC, van Nieuwpoort IC, van Schoor NM, et al. The Association of Serum Insulin-Like Growth Factor-I with Mortality, Cardiovascular Disease, and Cancer in the Elderly: A Population-Based Study.J Clin Endocrinol Metab 2010.</li><li>Arai Y, Takayama M, Gondo Y, et al. Adipose endocrine function, insulin-like growth factor-1 axis, and exceptional survival beyond 100 years of age.J Gerontol A Biol Sci Med Sci 2008, 63:1209-1218.</li><li>Johnsen SP, Hundborg HH, Sorensen HT, et al. Insulin-like growth factor (IGF) I, -II, and IGF binding protein-3 and risk of ischemic stroke.J Clin Endocrinol Metab 2005, 90:5937-5941.</li><li>Hankinson SE, Willett WC, Colditz GA, et al. Circulating concentrations of insulin-like growth factor-I and risk of breast cancer.Lancet 1998, 351:1393-1396.</li><li>Chan JM, Stampfer MJ, Giovannucci E, et al. Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study.Science 1998, 279:563-566.</li></ol>

<description>&lt;p&gt;&lt;strong&gt;References&lt;/strong&gt;&lt;/p&gt;&lt;ol&gt;&lt;li&gt;Chitnis MM, Yuen JS, Protheroe AS, et al. &lt;strong&gt;The type 1 insulin-like growth factor receptor pathway.&lt;/strong&gt;&lt;i&gt;Clin Cancer Res &lt;/i&gt;2008,&lt;strong&gt;14:&lt;/strong&gt;6364-6370.&lt;/li&gt;&lt;li&gt;Werner H, Bruchim I. &lt;strong&gt;The insulin-like growth factor-I receptor as an oncogene.&lt;/strong&gt;&lt;i&gt;Arch Physiol Biochem &lt;/i&gt;2009, &lt;strong&gt;115:&lt;/strong&gt;58-71.&lt;/li&gt;&lt;li&gt;Davies M, Gupta S, Goldspink G, Winslet M. &lt;strong&gt;The insulin-like growth factor system and colorectal cancer: clinical and experimental evidence.&lt;/strong&gt;&lt;i&gt;Int J Colorectal Dis &lt;/i&gt;2006, &lt;strong&gt;21:&lt;/strong&gt;201-208.&lt;/li&gt;&lt;li&gt;Sandhu MS, Dunger DB, Giovannucci EL. &lt;strong&gt;Insulin, insulin-like growth factor-I (IGF-I), IGF binding proteins, their biologic interactions, and colorectal cancer.&lt;/strong&gt;&lt;i&gt;J Natl Cancer Inst &lt;/i&gt;2002, &lt;strong&gt;94:&lt;/strong&gt;972-980.&lt;/li&gt;&lt;li&gt;Kaaks R. &lt;strong&gt;Nutrition, insulin, IGF-1 metabolism and cancer risk: a summary of epidemiological evidence.&lt;/strong&gt;&lt;i&gt;Novartis Found Symp &lt;/i&gt;2004, &lt;strong&gt;262:&lt;/strong&gt;247-260; discussion 260-268.&lt;/li&gt;&lt;li&gt;Lamberts SW, van den Beld AW, van der Lely AJ. &lt;strong&gt;The endocrinology of aging.&lt;/strong&gt;&lt;i&gt;Science &lt;/i&gt;1997, &lt;strong&gt;278:&lt;/strong&gt;419-424.&lt;/li&gt;&lt;li&gt;Doi T, Shimada H, Makizako H, et al. &lt;strong&gt;Association of insulin-like growth factor-1 with mild cognitive impairment and slow gait speed.&lt;/strong&gt;&lt;i&gt;Neurobiol Aging &lt;/i&gt;2015, &lt;strong&gt;36:&lt;/strong&gt;942-947.&lt;/li&gt;&lt;li&gt;Calvo D, Gunstad J, Miller LA, et al. &lt;strong&gt;Higher serum insulin-like growth factor-1 is associated with better cognitive performance in persons with mild cognitive impairment.&lt;/strong&gt;&lt;i&gt;Psychogeriatrics &lt;/i&gt;2013, &lt;strong&gt;13:&lt;/strong&gt;170-174.&lt;/li&gt;&lt;li&gt;Thissen JP, Ketelslegers JM, Underwood LE. &lt;strong&gt;Nutritional regulation of the insulin-like growth factors.&lt;/strong&gt;&lt;i&gt;Endocr Rev &lt;/i&gt;1994,&lt;strong&gt;15:&lt;/strong&gt;80-101.&lt;/li&gt;&lt;li&gt;Clemmons DR, Seek MM, Underwood LE. &lt;strong&gt;Supplemental essential amino acids augment the somatomedin-C/insulin-like growth factor I response to refeeding after fasting.&lt;/strong&gt;&lt;i&gt;Metabolism &lt;/i&gt;1985, &lt;strong&gt;34:&lt;/strong&gt;391-395.&lt;/li&gt;&lt;li&gt;Runchey SS, Pollak MN, Valsta LM, et al. &lt;strong&gt;Glycemic load effect on fasting and post-prandial serum glucose, insulin, IGF-1 and IGFBP-3 in a randomized, controlled feeding study.&lt;/strong&gt;&lt;i&gt;Eur J Clin Nutr &lt;/i&gt;2012, &lt;strong&gt;66:&lt;/strong&gt;1146-1152.&lt;/li&gt;&lt;li&gt;Brand-Miller JC, Liu V, Petocz P, Baxter RC. &lt;strong&gt;The glycemic index of foods influences postprandial insulin-like growth factor-binding protein responses in lean young subjects.&lt;/strong&gt;&lt;i&gt;Am J Clin Nutr &lt;/i&gt;2005, &lt;strong&gt;82:&lt;/strong&gt;350-354.&lt;/li&gt;&lt;li&gt;Biddinger SB, Ludwig DS. &lt;strong&gt;The insulin-like growth factor axis: a potential link between glycemic index and cancer.&lt;/strong&gt;&lt;i&gt;Am J Clin Nutr &lt;/i&gt;2005, &lt;strong&gt;82:&lt;/strong&gt;277-278.&lt;/li&gt;&lt;li&gt;Burgers AM, Biermasz NR, Schoones JW, et al. &lt;strong&gt;Meta-analysis and dose-response metaregression: circulating insulin-like growth factor I (IGF-I) and mortality.&lt;/strong&gt;&lt;i&gt;J Clin Endocrinol Metab &lt;/i&gt;2011, &lt;strong&gt;96:&lt;/strong&gt;2912-2920.&lt;/li&gt;&lt;li&gt;Ranke MB, Osterziel KJ, Schweizer R, et al. &lt;strong&gt;Reference levels of insulin-like growth factor I in the serum of healthy adults: comparison of four immunoassays.&lt;/strong&gt;&lt;i&gt;Clin Chem Lab Med &lt;/i&gt;2003, &lt;strong&gt;41:&lt;/strong&gt;1329-1334.&lt;/li&gt;&lt;li&gt;Bidlingmaier M, Friedrich N, Emeny RT, et al. &lt;strong&gt;Reference intervals for insulin-like growth factor-1 (igf-i) from birth to senescence: results from a multicenter study using a new automated chemiluminescence IGF-I immunoassay conforming to recent international recommendations.&lt;/strong&gt;&lt;i&gt;J Clin Endocrinol Metab &lt;/i&gt;2014, &lt;strong&gt;99:&lt;/strong&gt;1712-1721.&lt;/li&gt;&lt;li&gt;Brabant G, von zur Muhlen A, Wuster C, et al. &lt;strong&gt;Serum insulin-like growth factor I reference values for an automated chemiluminescence immunoassay system: results from a multicenter study.&lt;/strong&gt;&lt;i&gt;Horm Res &lt;/i&gt;2003, &lt;strong&gt;60:&lt;/strong&gt;53-60.&lt;/li&gt;&lt;li&gt;Crowe FL, Key TJ, Allen NE, et al. &lt;strong&gt;The association between diet and serum concentrations of IGF-I, IGFBP-1, IGFBP-2, and IGFBP-3 in the European Prospective Investigation into Cancer and Nutrition.&lt;/strong&gt;&lt;i&gt;Cancer Epidemiol Biomarkers Prev &lt;/i&gt;2009,&lt;strong&gt;18:&lt;/strong&gt;1333-1340.&lt;/li&gt;&lt;li&gt;Fontana L, Klein S, Holloszy JO. &lt;strong&gt;Long-term low-protein, low-calorie diet and endurance exercise modulate metabolic factors associated with cancer risk.&lt;/strong&gt;&lt;i&gt;Am J Clin Nutr &lt;/i&gt;2006, &lt;strong&gt;84:&lt;/strong&gt;1456-1462.&lt;/li&gt;&lt;li&gt;Fontana L, Weiss EP, Villareal DT, et al. &lt;strong&gt;Long-term effects of calorie or protein restriction on serum IGF-1 and IGFBP-3 concentration in humans.&lt;/strong&gt;&lt;i&gt;Aging Cell &lt;/i&gt;2008, &lt;strong&gt;7:&lt;/strong&gt;681-687.&lt;/li&gt;&lt;li&gt;Friedrich N, Haring R, Nauck M, et al. &lt;strong&gt;Mortality and serum insulin-like growth factor (IGF)-I and IGF binding protein 3 concentrations.&lt;/strong&gt;&lt;i&gt;J Clin Endocrinol Metab &lt;/i&gt;2009, &lt;strong&gt;94:&lt;/strong&gt;1732-1739.&lt;/li&gt;&lt;li&gt;Carlzon D, Svensson J, Petzold M, et al. &lt;strong&gt;Both low and high serum IGF-1 levels associate with increased risk of cardiovascular events in elderly men.&lt;/strong&gt;&lt;i&gt;J Clin Endocrinol Metab &lt;/i&gt;2014, &lt;strong&gt;99:&lt;/strong&gt;E2308-2316.&lt;/li&gt;&lt;li&gt;Svensson J, Carlzon D, Petzold M, et al. &lt;strong&gt;Both low and high serum IGF-I levels associate with cancer mortality in older men.&lt;/strong&gt;&lt;i&gt;J Clin Endocrinol Metab &lt;/i&gt;2012, &lt;strong&gt;97:&lt;/strong&gt;4623-4630. .&lt;/li&gt;&lt;li&gt;van Bunderen CC, van Nieuwpoort IC, van Schoor NM, et al. &lt;strong&gt;The Association of Serum Insulin-Like Growth Factor-I with Mortality, Cardiovascular Disease, and Cancer in the Elderly: A Population-Based Study.&lt;/strong&gt;&lt;i&gt;J Clin Endocrinol Metab &lt;/i&gt;2010.&lt;/li&gt;&lt;li&gt;Arai Y, Takayama M, Gondo Y, et al. &lt;strong&gt;Adipose endocrine function, insulin-like growth factor-1 axis, and exceptional survival beyond 100 years of age.&lt;/strong&gt;&lt;i&gt;J Gerontol A Biol Sci Med Sci &lt;/i&gt;2008, &lt;strong&gt;63:&lt;/strong&gt;1209-1218.&lt;/li&gt;&lt;li&gt;Johnsen SP, Hundborg HH, Sorensen HT, et al. &lt;strong&gt;Insulin-like growth factor (IGF) I, -II, and IGF binding protein-3 and risk of ischemic stroke.&lt;/strong&gt;&lt;i&gt;J Clin Endocrinol Metab &lt;/i&gt;2005, &lt;strong&gt;90:&lt;/strong&gt;5937-5941.&lt;/li&gt;&lt;li&gt;Hankinson SE, Willett WC, Colditz GA, et al. &lt;strong&gt;Circulating concentrations of insulin-like growth factor-I and risk of breast cancer.&lt;/strong&gt;&lt;i&gt;Lancet &lt;/i&gt;1998, &lt;strong&gt;351:&lt;/strong&gt;1393-1396.&lt;/li&gt;&lt;li&gt;Chan JM, Stampfer MJ, Giovannucci E, et al. &lt;strong&gt;Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study.&lt;/strong&gt;&lt;i&gt;Science &lt;/i&gt;1998, &lt;strong&gt;279:&lt;/strong&gt;563-566.&lt;/li&gt;&lt;/ol&gt;
</description>

What’s the secret to living a long, vibrant life? If you’re like most people, you’ve probably considered it—maybe even searched for it. What if I told you that the key to slowing down the aging process, keeping your body and mind sharp, and living the longest, healthiest life possible could all come down to one thing: what’s on your plate?

That’s exactly what we uncover in this latest episode of the Eat to Live podcast. I’m joined by my daughter, Jenna. Together, we take a journey into the heart of what makes us age faster, or slower, depending on our choices.

Anti-Aging and Longevity

<description>Dr. Fuhrman and his daughter Jenna unveil the powerful connection between emotional wisdom and healthy eating. Learn how mastering your emotions can lead to effortless weight loss and improved overall health. This groundbreaking approach offers a safe and easy way to transform your relationship with food, boost your confidence, and achieve lasting results without strict diets.
</description>

Dr. Fuhrman and his daughter Jenna unveil the powerful connection between emotional wisdom and healthy eating. Learn how mastering your emotions can lead to effortless weight loss and improved overall health. This groundbreaking approach offers a safe and easy way to transform your relationship with food, boost your confidence, and achieve lasting results without strict diets.

Emotional Wisdom

<description>Welcome to another episode of the Eat to Live podcast! Today, Dr. Fuhrman and his daughter, Jenna Fuhrman, delve into the critical topics of diabetes, fiber, and blood sugar. Diabetes and pre-diabetes are on the rise globally. Dr. Fuhrman explains how a whole food, plant-based diet will manage and even reverse your diabetes. Tune in to find out how.
</description>

Welcome to another episode of the Eat to Live podcast! Today, Dr. Fuhrman and his daughter, Jenna Fuhrman, delve into the critical topics of diabetes, fiber, and blood sugar. Diabetes and pre-diabetes are on the rise globally. Dr. Fuhrman explains how a whole food, plant-based diet will manage and even reverse your diabetes. Tune in to find out how.

The Foods to Reverse Your Diabetes

<description>In this exciting episode, Dr. Fuhrman and his daughter, Jenna, dive deep into a topic that is crucial for our health: fats.

Dr. Fuhrman explains why fats are essential for our body to thrive and survive. He discusses the importance of maintaining a balanced intake of all macronutrients – carbohydrates, fats, proteins, and even water.

Good Fats vs. Bad Fats: Understanding the difference between good and bad fats is crucial. Dr. Fuhrman emphasizes the health benefits of whole food sources of fats like nuts, seeds, and avocados compared to the detrimental effects of oils and animal fats commonly found in modern diets.

Health Risks of Low Fat Intake: The episode also touches on the potential health problems that can arise from a diet too low in fat, highlighting the importance of maintaining an adequate fat intake.

Common Misconceptions: Dr. Fuhrman debunks common myths about fats, explaining how studies on fat intake often misrepresent the benefits and risks by not distinguishing between different types of fats.

Tune in to this episode to learn more about how you can optimize your fat intake for better health. Whether you're looking to understand the basics of macronutrients or dive into the specifics of fat consumption, this episode is packed with valuable insights and practical advice.
</description>

In this exciting episode, Dr. Fuhrman and his daughter, Jenna, dive deep into a topic that is crucial for our health: fats.

Dr. Fuhrman explains why fats are essential for our body to thrive and survive. He discusses the importance of maintaining a balanced intake of all macronutrients – carbohydrates, fats, proteins, and even water.

Good Fats vs. Bad Fats: Understanding the difference between good and bad fats is crucial. Dr. Fuhrman emphasizes the health benefits of whole food sources of fats like nuts, seeds, and avocados compared to the detrimental effects of oils and animal fats commonly found in modern diets.

Health Risks of Low Fat Intake: The episode also touches on the potential health problems that can arise from a diet too low in fat, highlighting the importance of maintaining an adequate fat intake.

Common Misconceptions: Dr. Fuhrman debunks common myths about fats, explaining how studies on fat intake often misrepresent the benefits and risks by not distinguishing between different types of fats.

Tune in to this episode to learn more about how you can optimize your fat intake for better health. Whether you're looking to understand the basics of macronutrients or dive into the specifics of fat consumption, this episode is packed with valuable insights and practical advice.

The Essential Role of Fats

Our health is our most precious gift and smart nutrition can change your life. Each month, join Dr. Fuhrman and his daughter, Jenna Fuhrman as they discuss important topics in the world of nutrition. Eat to Live will change the way you eat and think about food.

Eat to Live

Details

Recent Episodes